Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VIMKUNYA® safely and effectively. See full prescribing information for VIMKUNYA® . VIMKUNYA® (Chikungunya Vaccine, Recombinant) injectable suspension, for intramuscular use Initial U.S. Approval: 2025
Medication labelWhy this: Advisory · dailymed-other
VIMKUNYA is a vaccine indicated for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 12 years of age and older. This indication is approved under accelerated approval based on anti-CHIKV neutralizing antibody levels [see Clinical Studies (14)]. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
- generic_name
- chikungunya vaccine, recombinant
- product_names
- Chikungunya Vaccine, Recombinant
- ndc
- 50632-018, 50632-018-04, 50632-018-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en